Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Modified virus tested as new weapon against tough cancers

NCT ID NCT07262164

Summary

This is an early-stage safety study testing a new therapy called VG2062 in people with advanced solid tumors that have stopped responding to standard treatments. VG2062 is a modified virus designed to infect and kill cancer cells. The main goal is to find a safe dose and understand the side effects in about 30 participants.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT SOLID TUMOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • No. 67, Huayuan Road, Langfang Economic and Technological Development Zone, Hebei Province

    RECRUITING

    Hebei, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.